Melbourne, Australia
Based in
+61 412 520598
Customer Support
Sales@ausamics.com
Online sale always open
Clindamycin Hydrochloride Powder
Belongs to lincosamide class and inhibits protein synthesis
Catalog Number: AS-2009
CAS Number: 21462-39-5
MW: 461.44 g/mol
MF: C18H34Cl2N2O5S
A strong lincosamide antibiotic used in microbiology, clindamycin hydrochloride powder works well against a range of bacterial strains.
It inhibits protein synthesis at the 50S ribosome level, which stops the growth of bacteria. Clindamycin is very effective against Gram-positive and anaerobic bacteria because of its focused action. Since more broad-spectrum antibiotics are now available, clindamycin is not regarded as a first-line option, even if some Gram-negative bacteria are sensitive.
| Cat. Number | AS-2009 |
| CAS Number | 21462-39-5 |
| Additional CAS | 18323-44-9 |
| Additional CAS | 58207-19-5 |
| MDL Number | MFCD07793327 |
| Pubchem | 310270392 |
| Molecular Weight | 461.44 g/mol |
| Molecular Formula | C18H34Cl2N2O5S |
| Storage Temperature | 4°C |
| Form and Color | Powder to crystalline powder, white to off-white |
| Assay | ≥ 800 µg/mg |
| pH (10% in water) | 3 – 5.5 |
| Water | 3 – 6% |
| 1H-NMR Spectrum | Corresponds to assigned structure. |
| Synonym | Cleocin; (7S)-7-Chloro-7-deoxylincomycin hydrochloride |
